Literature DB >> 22257181

Cardiac autonomic dysfunction in anabolic steroid users.

A S Maior1, A R Carvalho, S R Marques-Neto, P Menezes, P P Soares, J H M Nascimento.   

Abstract

This study aimed to evaluate if androgenic-anabolic steroids (AAS) abuse may induce cardiac autonomic dysfunction in recreational trained subjects. Twenty-two men were volunteered for the study. The AAS group (n = 11) utilized AAS at mean dosage of 410 ± 78.6 mg/week. All of them were submitted to submaximal exercise testing using an Astrand-Rhyming protocol. Electrocardiogram (ECG) and respired gas analysis were monitored at rest, during, and post-effort. Mean values of VO2 , VCO2 , and VE were higher in AAS group only at rest. The heart rate variability variables were calculated from ECG using MATLAB-based algorithms. At rest, AAS group showed lower values of the standard deviation of R-R intervals, the proportion of adjacent R-R intervals differing by more than 50 ms (pNN50), the root mean square of successive differences (RMSSD), and the total, the low-frequency (LF) and the high-frequency (HF) spectral power, as compared to Control group. After submaximal exercise testing, pNN50, RMSSD, and HF were lower, and the LF/HF ratio was higher in AAS group when compared to control group. Thus, the use of supraphysiological doses of AAS seems to induce dysfunction in tonic cardiac autonomic regulation in recreational trained subjects.
© 2012 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  androgenic-anabolic steroids; heart rate variability; submaximal exercise testing

Mesh:

Substances:

Year:  2012        PMID: 22257181     DOI: 10.1111/j.1600-0838.2011.01436.x

Source DB:  PubMed          Journal:  Scand J Med Sci Sports        ISSN: 0905-7188            Impact factor:   4.221


  7 in total

Review 1.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

2.  Long-term anabolic steroids in male bodybuilders induce cardiovascular structural and autonomic abnormalities.

Authors:  Octávio Barbosa Neto; Gustavo Ribeiro da Mota; Carla Cristina De Sordi; Elisabete Aparecida M R Resende; Luiz Antônio P R Resende; Marco Antônio Vieira da Silva; Moacir Marocolo; Rafael Silva Côrtes; Lucas Felipe de Oliveira; Valdo José Dias da Silva
Journal:  Clin Auton Res       Date:  2017-10-10       Impact factor: 4.435

3.  Ventricular structure, function, and focal fibrosis in anabolic steroid users: a CMR study.

Authors:  Peter J Angell; Tevfik F Ismail; Andrew Jabbour; Gillian Smith; Annette Dahl; Ricardo Wage; Greg Whyte; Daniel J Green; Sanjay Prasad; Keith George
Journal:  Eur J Appl Physiol       Date:  2014-01-28       Impact factor: 3.078

4.  Androgenic-anabolic steroids inhibited post-exercise hypotension: a case control study.

Authors:  Jefferson F C R Junior; Alexandre S Silva; Glêbia A Cardoso; Valmir O Silvino; Maria C C Martins; Marcos A P Santos
Journal:  Braz J Phys Ther       Date:  2017-07-11       Impact factor: 3.377

Review 5.  How the love of muscle can break a heart: Impact of anabolic androgenic steroids on skeletal muscle hypertrophy, metabolic and cardiovascular health.

Authors:  Deaglan McCullough; Richard Webb; Kevin J Enright; Katie E Lane; Jim McVeigh; Claire E Stewart; Ian G Davies
Journal:  Rev Endocr Metab Disord       Date:  2020-12-02       Impact factor: 6.514

6.  The anabolic androgenic steroid nandrolone decanoate disrupts redox homeostasis in liver, heart and kidney of male Wistar rats.

Authors:  Stephan P Frankenfeld; Leonardo P Oliveira; Victor H Ortenzi; Igor C C Rego-Monteiro; Elen A Chaves; Andrea C Ferreira; Alvaro C Leitão; Denise P Carvalho; Rodrigo S Fortunato
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

Review 7.  A Meta-Analysis on Sex Differences in Resting-State Vagal Activity in Children and Adolescents.

Authors:  Julian Koenig; Joshua A Rash; Tavis S Campbell; Julian F Thayer; Michael Kaess
Journal:  Front Physiol       Date:  2017-08-24       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.